Skip to main content

uncategorized

AbbVie Invests $380M to Expand Illinois Manufacturing for Neuroscience, Obesity Meds

By Admin Source: Insurance Journal
AbbVie Invests $380M to Expand Illinois Manufacturing for Neuroscience, Obesity Meds

AbbVie announced a $380 million investment to construct two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus, aimed at expanding domestic production capacity for neuroscience and obesity medications. The expansion reflects growing demand for these therapeutic areas and represents the company's commitment to strengthening U.S. manufacturing capabilities.

Read Full Article at Insurance Journal

Related Articles